Skip to main content
Erschienen in: Digestive Diseases and Sciences 7/2010

01.07.2010 | Review

Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis

verfasst von: Jing Wang, Hai-Feng Pan, Yun-Tao Hu, Yu Zhu, Qian He

Erschienen in: Digestive Diseases and Sciences | Ausgabe 7/2010

Einloggen, um Zugang zu erhalten

Abstract

Background

The relationship of gastric cancer to the presence of interleukin-8 (IL-8) 251 T/A has been reported with conflicting results.

Aim

To further explore the association of IL-8 251 allele polymorphism with gastric cancer susceptibility.

Methods

We performed an extensive search of relevant studies and carried out a meta-analysis, including ten studies with 2,195 gastric cancer cases and 3,505 controls, to obtain a more precise estimate.

Results

The combined results based on all studies showed that the IL-8 251 allele AA genotype was a risk factor for gastric cancer [AA versus TT: odds ratio (OR) = 1.363, 95% confidence interval (CI): 1.199–1.527]. In subgroup analysis, a clear effect of AA in IL-8 251 allele was shown in Asians (AA versus TT: OR = 1.593, 95% CI: 1.013–2.173) but not in Caucasians or Mexicans. When stratified by Lauren classification, we found that the IL-8 251 allele TA and AA polymorphism was significantly associated with the diffuse type of gastric cancer (TA versus TT: OR = 1.448, 95% CI: 1.177–1.720; AA versus TT: OR = 1.586, 95% CI: 1.128–2.044). The IL-8 251 AA genotype was found to be a risk factor for cardiac gastric cancer (AA versus TT: OR = 1.840, 95% CI: 1.112–2.568) but not for noncardiac gastric cancer.

Conclusions

This meta-analysis suggested that IL-8 251 allele A>T polymorphism might be a risk factor for gastric cancer.
Literatur
1.
Zurück zum Zitat Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002;12:111–127.CrossRefPubMed Terry MB, Gaudet MM, Gammon MD. The epidemiology of gastric cancer. Semin Radiat Oncol. 2002;12:111–127.CrossRefPubMed
2.
Zurück zum Zitat Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156.CrossRefPubMed Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153–156.CrossRefPubMed
3.
Zurück zum Zitat Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11–25.CrossRefPubMed Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2006. CA Cancer J Clin. 2006;56:11–25.CrossRefPubMed
5.
Zurück zum Zitat Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545.CrossRefPubMed Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357:539–545.CrossRefPubMed
6.
Zurück zum Zitat Macarthur M, Hold GL, EI-Omar EM. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphism in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004;286:G515–G520.CrossRefPubMed Macarthur M, Hold GL, EI-Omar EM. Inflammation and cancer II. Role of chronic inflammation and cytokine gene polymorphism in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol. 2004;286:G515–G520.CrossRefPubMed
7.
Zurück zum Zitat Gianfagna F, De Feo E, van Duijn CM, Ricciardi G, Boccia S. A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics. 2008;9(6):361–374.CrossRefPubMed Gianfagna F, De Feo E, van Duijn CM, Ricciardi G, Boccia S. A systematic review of meta-analyses on gene polymorphisms and gastric cancer risk. Curr Genomics. 2008;9(6):361–374.CrossRefPubMed
8.
Zurück zum Zitat Kitadai Y, Haruma K, Sumii K, et al. Expression of interleukin-8 correlates with vascularity in human gastric cancers. Am J Pathol. 1998;152:93–100.PubMed Kitadai Y, Haruma K, Sumii K, et al. Expression of interleukin-8 correlates with vascularity in human gastric cancers. Am J Pathol. 1998;152:93–100.PubMed
9.
Zurück zum Zitat Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science. 1992;258:1798–1801.CrossRefPubMed Koch AE, Polverini PJ, Kunkel SL, et al. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science. 1992;258:1798–1801.CrossRefPubMed
10.
Zurück zum Zitat Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphism with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol. 2006;12(32):5205–5210.PubMed Kamali-Sarvestani E, Bazargani A, Masoudian M, Lankarani K, Taghavi AR, Saberifiroozi M. Association of H pylori cagA and vacA genotypes and IL-8 gene polymorphism with clinical outcome of infection in Iranian patients with gastrointestinal diseases. World J Gastroenterol. 2006;12(32):5205–5210.PubMed
11.
Zurück zum Zitat Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:2251–2257.PubMed Savage SA, Abnet CC, Mark SD, et al. Variants of the IL8 and IL8RB genes and risk for gastric cardia adenocarcinoma and esophageal squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2004;13:2251–2257.PubMed
12.
Zurück zum Zitat Lee WP, Tai DI, Lan KH, et al. The 251 T allele of the interleukin-8 promoter is associated with increased risk of gastric cancer featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005;11:6431–6441.CrossRefPubMed Lee WP, Tai DI, Lan KH, et al. The 251 T allele of the interleukin-8 promoter is associated with increased risk of gastric cancer featuring diffuse-type histopathology in Chinese population. Clin Cancer Res. 2005;11:6431–6441.CrossRefPubMed
13.
Zurück zum Zitat Lu WL, Pan KF, Zhang L, Lin DX, Miao XP, You WC. Genetic polymorphism of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–636.CrossRefPubMed Lu WL, Pan KF, Zhang L, Lin DX, Miao XP, You WC. Genetic polymorphism of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor alpha and risk of gastric cancer in a Chinese population. Carcinogenesis. 2005;26:631–636.CrossRefPubMed
14.
Zurück zum Zitat Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8–251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330–335.CrossRefPubMed Ohyauchi M, Imatani A, Yonechi M, et al. The polymorphism interleukin 8–251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut. 2005;54:330–335.CrossRefPubMed
15.
Zurück zum Zitat Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14:2487–2493.CrossRefPubMed Taguchi A, Ohmiya N, Shirai K, et al. Interleukin-8 promoter polymorphism increases the risk of atrophic gastritis and gastric cancer in Japan. Cancer Epidemiol Biomarkers Prev. 2005;14:2487–2493.CrossRefPubMed
16.
Zurück zum Zitat Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphism in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–125.CrossRefPubMed Kamangar F, Abnet CC, Hutchinson AA, et al. Polymorphism in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control. 2006;17:117–125.CrossRefPubMed
17.
Zurück zum Zitat Shirai K, Ohmiya N, Taguchi A, et al. Interleukin-8 gene polymorphism associated with susceptibility to non-cardiac gastric cancer with micro satellite instability. J Gastroenterol Hepatol. 2006;21(7):1129–1135.CrossRefPubMed Shirai K, Ohmiya N, Taguchi A, et al. Interleukin-8 gene polymorphism associated with susceptibility to non-cardiac gastric cancer with micro satellite instability. J Gastroenterol Hepatol. 2006;21(7):1129–1135.CrossRefPubMed
18.
Zurück zum Zitat Savage SA, Hou L, Lissowska J, Chow WH, Zatonski W, Chanock SJ. Yeager M Interleukin-8 polymorphism are not associated with gastric cancer risk in a polish population. Cancer Epidemiol Biomarkers Prev. 2006;15:589–591.CrossRefPubMed Savage SA, Hou L, Lissowska J, Chow WH, Zatonski W, Chanock SJ. Yeager M Interleukin-8 polymorphism are not associated with gastric cancer risk in a polish population. Cancer Epidemiol Biomarkers Prev. 2006;15:589–591.CrossRefPubMed
19.
Zurück zum Zitat Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Thr399Ile and interleukin-8 -251 polymorphism in the risk for the development of distal gastric cancer. BMC Cancer. 2007;7:70.CrossRefPubMed Garza-Gonzalez E, Bosques-Padilla FJ, Mendoza-Ibarra SI, et al. Thr399Ile and interleukin-8 -251 polymorphism in the risk for the development of distal gastric cancer. BMC Cancer. 2007;7:70.CrossRefPubMed
20.
Zurück zum Zitat Canedo P, Castanheira-Vale AJ, Lunet N, Pereira F, et al. The interleukin-8–251*T/*A polymorphism is not associated with risk for gastric cancer development in a Portuguese population. Eur J Cancer Prev. 2008;17(1):28–32.CrossRefPubMed Canedo P, Castanheira-Vale AJ, Lunet N, Pereira F, et al. The interleukin-8–251*T/*A polymorphism is not associated with risk for gastric cancer development in a Portuguese population. Eur J Cancer Prev. 2008;17(1):28–32.CrossRefPubMed
21.
Zurück zum Zitat Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case–control study. Ann Rheum Dis. 1998;57:451–455.CrossRefPubMed Hardy CJ, Palmer BP, Muir KR, Sutton AJ, Powell RJ. Smoking history, alcohol consumption, and systemic lupus erythematosus: a case–control study. Ann Rheum Dis. 1998;57:451–455.CrossRefPubMed
22.
Zurück zum Zitat Harris T, Creed F, Brugha TS. Stressful life events and Graves’ disease. Br J Psychiatry. 1992;161:535–541.CrossRefPubMed Harris T, Creed F, Brugha TS. Stressful life events and Graves’ disease. Br J Psychiatry. 1992;161:535–541.CrossRefPubMed
23.
Zurück zum Zitat Lu Y, Wang ZD, Shen J, Xu YC. Meta-analysis on the relationship between IL8–251 gene polymorphism and gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2007;41(Suppl.):39–42.PubMed Lu Y, Wang ZD, Shen J, Xu YC. Meta-analysis on the relationship between IL8–251 gene polymorphism and gastric cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2007;41(Suppl.):39–42.PubMed
24.
Zurück zum Zitat Fujihara J, Shiwaku K, Yasuda T, et al. Variation of interleukin 8 −251 A>T polymorphism worldwide populations and intra-ethnic differences in Japanese populations. Clin Chim Acta. 2007;377:79–82.CrossRefPubMed Fujihara J, Shiwaku K, Yasuda T, et al. Variation of interleukin 8 −251 A>T polymorphism worldwide populations and intra-ethnic differences in Japanese populations. Clin Chim Acta. 2007;377:79–82.CrossRefPubMed
25.
Zurück zum Zitat Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306–309.CrossRefPubMed Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306–309.CrossRefPubMed
26.
Zurück zum Zitat Wang LD, Zheng S, Zheng ZY, et al. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol. 2003;9:1156–1164.PubMed Wang LD, Zheng S, Zheng ZY, et al. Primary adenocarcinomas of lower esophagus, esophagogastric junction and gastric cardia: in special reference to China. World J Gastroenterol. 2003;9:1156–1164.PubMed
27.
Zurück zum Zitat Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–6740.PubMed Correa P. Human gastric carcinogenesis: a multistep and multifactorial process—first American cancer society award lecture on cancer epidemiology and prevention. Cancer Res. 1992;52:6735–6740.PubMed
28.
Zurück zum Zitat Ito H, Matsuo K, Hamajima N, et al. Significant association of interleukin 8-251T/A polymorphism with smoking behavior in a Japanese population. J Hum Genet. 2005;50:567–573.CrossRefPubMed Ito H, Matsuo K, Hamajima N, et al. Significant association of interleukin 8-251T/A polymorphism with smoking behavior in a Japanese population. J Hum Genet. 2005;50:567–573.CrossRefPubMed
Metadaten
Titel
Polymorphism of IL-8 in 251 Allele and Gastric Cancer Susceptibility: A Meta-Analysis
verfasst von
Jing Wang
Hai-Feng Pan
Yun-Tao Hu
Yu Zhu
Qian He
Publikationsdatum
01.07.2010
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 7/2010
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0978-y

Weitere Artikel der Ausgabe 7/2010

Digestive Diseases and Sciences 7/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

GLP-1-Agonisten können Fortschreiten diabetischer Retinopathie begünstigen

24.05.2024 Diabetische Retinopathie Nachrichten

Möglicherweise hängt es von der Art der Diabetesmedikamente ab, wie hoch das Risiko der Betroffenen ist, dass sich sehkraftgefährdende Komplikationen verschlimmern.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.